| carbidopa/levodopa / Generic mfg. |
NCT00558337: Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease |
|
|
| Completed | 2 | 78 | RoW | levodopa-carbidopa | Osmotica Pharmaceutical US LLC | Parkinson's Disease | 12/08 | 12/08 | | |
|
NCT00745277: High and Low Dose Treatment of Carbidopa in Parkinson's Disease |
|
|
| Completed | 2 | 12 | US | Carbidopa-Levodopa, Sinemet, Carbidopa- Levodopa, sinemet | Oregon Health and Science University, Parkinson Disease Research, Education and Clinical Center at Portland VA Hospital, RJG Foundation, Oregon Clinical and Translational Research Institute | Parkinson's Disease | 03/11 | 05/11 | | |
NCT00947037: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study |
|
|
| Withdrawn | 2 | 0 | RoW | AP-CD/LD | Intec Pharma Ltd. | Parkinson's Disease | 08/12 | | | |
| Completed | 2 | 25 | Europe, RoW | CVT-301, Placebo, Sinemet (carbidopa/levodopa) | Acorda Therapeutics, Michael J. Fox Foundation for Parkinson's Research | Idiopathic Parkinson's Disease | 11/12 | 12/12 | | |
|
|
| Withdrawn | 2 | 0 | US | Levodopa, Sinemet, Zolpidem first dose, Ambien, Zolpidem second dose, sugar pill, Placebo | Rush University Medical Center | Parkinson's Disease | | | | |
NCT00491998 / 2006-004112-51: PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets |
|
|
| Completed | 1/2 | 27 | Europe | V1512, V1512 and Entacapone | Vernalis (R&D) Ltd, Cita NeuroPharmaceuticals, Syneos Health | Parkinson's Disease | 11/07 | 11/07 | | |
